- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03868644
The Impact of VCT and Condom Distribution as HIV Prevention Strategies Among Youth in Kenya
HIV Prevention Among Youth: A Randomized Controlled Trial of Voluntary Counseling and Testing for HIV and Male Condom Distribution in Rural Kenya
The vast majority of new HIV infections occur in sub-Saharan Africa, where nearly 2 million people become infected with HIV/AIDS every year. Forty-five percent of these new HIV infections occur among people under 25 years old, and nearly all of them are due to unprotected sex. Ensuring the adoption of safer sexual behavior among youth is critical to keeping the new generations free of HIV.
This research study aims to examine, through a large randomized controlled trial, the impact of two HIV prevention strategies among a youth population in Kenya: Voluntary Counseling and Testing for HIV (VCT), and condom distribution.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Youth previously participated in an earlier study by Duflo, Dupas and Kremer in 328 primary schools in the same study site in Western Province, Kenya who consent to participate.
Exclusion Criteria:
Youth sampled for the study who do not consent to participate.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Voluntary Counseling and Testing for HIV (VCT)
Youth are offered VCT conducted onsite via mobile clinics in accordance with Kenya National HIV Testing Guidelines by certified VCT counselors trained by the National AIDS and STI Control Program (NASCOP).
|
Youth are offered VCT conducted onsite via mobile clinics in accordance with Kenya National HIV Testing Guidelines by certified VCT counselors trained by the National AIDS and STI Control Program (NASCOP).
|
EXPERIMENTAL: Condoms
Youth are offered 50 packages containing 3 condoms each of Trust brand condoms free of charge.
|
Youth are offered 50 packages containing 3 condoms each of Trust brand condoms free of charge.
|
EXPERIMENTAL: VCT and Condoms
Youth are offered both VCT and condoms.
|
Youth are offered VCT conducted onsite via mobile clinics in accordance with Kenya National HIV Testing Guidelines by certified VCT counselors trained by the National AIDS and STI Control Program (NASCOP).
Youth are offered 50 packages containing 3 condoms each of Trust brand condoms free of charge.
|
NO_INTERVENTION: Control
No intervention is provided (beyond the standard available HIV prevention services within the area)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
HSV-2 prevalence
Time Frame: 2 years post-intervention
|
Assessed via a blood test
|
2 years post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
% of youth who have high HIV knowledge
Time Frame: 2 years post-intervention
|
Assessed via a questionnaire
|
2 years post-intervention
|
% of youth who did not use a condom at last intercourse
Time Frame: 2 years post-intervention
|
Assessed via a questionnaire
|
2 years post-intervention
|
% of youth who reported having an STI or symptoms of an STI
Time Frame: 2 years post-intervention
|
Assessed via a questionnaire
|
2 years post-intervention
|
% of youth who report ever being pregnant
Time Frame: 2 years post-intervention
|
Assessed via a questionnaire
|
2 years post-intervention
|
Number of sexual partners
Time Frame: 2 years post-intervention
|
Assessed via a questionnaire
|
2 years post-intervention
|
HIV prevalence
Time Frame: 2 years post-intervention
|
Assessed via a blood test
|
2 years post-intervention
|
% of youth who have accepting attitudes towards people living with HIV (PLHIV)
Time Frame: 2 years post-intervention
|
Assessed via a questionnaire
|
2 years post-intervention
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Esther Duflo, Massachusetts Institute of Technology
- Principal Investigator: Pascaline Dupas, Stanford University
- Principal Investigator: Vandana Sharma, Harvard School of Public Health (HSPH)
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Immune System Diseases
- Slow Virus Diseases
- HIV Infections
- Acquired Immunodeficiency Syndrome
Other Study ID Numbers
- 0809002873R010
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV/AIDS
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of California, San DiegoNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
University of Massachusetts, BostonCompleted
-
Stanford UniversityJanssen Services, LLCCompleted
-
ViiV HealthcareJohns Hopkins University; Pfizer; Vanderbilt University; University of North Carolina...Completed
-
Medical College of WisconsinCompleted
-
Emory UniversityCompleted
-
Rhode Island HospitalUnknown
-
Tibotec Pharmaceuticals, IrelandCompleted
-
Lampiris, Harry W., M.D.AbbottUnknown
Clinical Trials on Voluntary Counseling and Testing for HIV (VCT)
-
Imperial College LondonUniversity of Cape TownCompleted
-
Emory UniversityNational Institute of Mental Health (NIMH)Completed
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)Completed
-
Makerere UniversityUniversity of California, San FranciscoCompleted
-
University of California, Los AngelesEmory University; BroadReach Healthcare; USAID, South Africa; South African Department...CompletedHIV Infections | HIV Seropositivity | ARTSouth Africa
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHIV InfectionsSouth Africa
-
National Development and Research Institutes, Inc.National Institute on Drug Abuse (NIDA)Completed
-
Hunter College of City University of New YorkNational Institute on Drug Abuse (NIDA); University of MichiganEnrolling by invitationHIV InfectionsUnited States
-
University of WashingtonCompletedPregnancy | HIV Counseling and Testing | Home Based | Male PartnerKenya
-
Medical College of WisconsinNational Institute of Mental Health (NIMH)Enrolling by invitation